The dramatic race to find a vaccination for the pandemic. Pfizer and BioNTech is enrolling people for phase 3 of its COVID-19 vaccine trial. The study has around 44,000 participants worldwide, 800 of them in South Africa. Dr Bha Ndungane-Tlakula, Pfizer’s Medical Director for South Africa, shares more on this.